TY2-27456-47825
1 vaccination
1 coded response
7 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 480 / MI
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Registered in v-safe
-
2021-01-18
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Health check-in — day 0, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-18
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-19
- 2021-01-20
-
2021-01-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-23
- 2021-01-25
-
2021-02-19
Call successfulParticipant prefers to complete VAERS report online
- 2021-04-19
-
2022-01-18
Survey response — 12 months, dose 1MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Sore throat, mild congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech |
Call center
2 call center cases
2 successful
Free text
Release 10 — 12 months, dose 1
Symptoms: Sore throat, mild congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release